Clinical Trial Update: Study Adding Drugs to Usual Treatment for Large B-Cell Lymphoma That Returned or Did Not Respond to Treatment [Phase 2]

View source ↗

Summary

This SWOG Cancer Research Network Phase 2 trial is evaluating adding drugs to standard therapy for large B-cell lymphoma that has returned or did not respond to…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diffuse Large B-cell Lymphoma
• Follicular Lymphoma Grade 3b
• High-grade B-cell Lymphoma
• High-grade B-cell Lymphoma with Myc and Bcl2 and or Bcl6 Rearrangements
• Transformed Non-hodgkin Lymphoma

Drugs mentioned

• Not disclosed

Snippet

Sponsor: SWOG Cancer Research Network | Conditions: Grade 3b Follicular Lymphoma, High Grade B-Cell Lymphoma | Phase 2 | Status: RECRUITING